Lawrence Steinman - Jun 2, 2023 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Director
Signature
/s/ Larry Steinman
Stock symbol
KTTA
Transactions as of
Jun 2, 2023
Transactions value $
$12,930
Form type
4
Date filed
6/6/2023, 09:00 PM
Previous filing
Jun 2, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Purchase $12.9K +30K +2.31% $0.43 1.33M Jun 2, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.38 to $0.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.